These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 8442272

  • 1. Effect of immunosuppression on chronic rejection in the rat aortic allograft model.
    Belitsky P, Gulanikar A, He G, Gupta R.
    Transplant Proc; 1993 Feb; 25(1 Pt 2):935. PubMed ID: 8442272
    [No Abstract] [Full Text] [Related]

  • 2. Effects of leflunomide and cyclosporine on aortic allograft chronic rejection in the rat.
    MacDonald AS, Sabr K, MacAuley MA, McAlister VC, Bitter-Suermann H, Lee T.
    Transplant Proc; 1994 Dec; 26(6):3244-5. PubMed ID: 7998130
    [No Abstract] [Full Text] [Related]

  • 3. Synergistic effect of rapamycin and cyclosporine in pancreaticoduodenal transplantation in the rat.
    Chen H, Wu J, Luo H, Daloze P.
    Transplant Proc; 1992 Jun; 24(3):892-3. PubMed ID: 1604658
    [No Abstract] [Full Text] [Related]

  • 4. Triple-drug immunosuppression significantly reduces chronic rejection in noninfected and RCMV-infected rats.
    Lemström K, Bruning J, Koskinen P, Bruggeman C, Lautenschlager I, Häyry P.
    Transplant Proc; 1994 Jun; 26(3):1727-8. PubMed ID: 8030105
    [No Abstract] [Full Text] [Related]

  • 5. Effect of Neoral or cyclosporine on the development of chronic rejection in an aortic allograft rat model.
    Little DM, Stoltenberg RL, Hullett DA, Sollinger HW.
    Transplant Proc; 1996 Apr; 28(2):880-1. PubMed ID: 8623445
    [No Abstract] [Full Text] [Related]

  • 6. Cyclosporine inhibits intimal hyperplasia in rat aortic allografts.
    Stoltenberg R, Geraghty J, Steele DM, Kennedy E, Hullett DA, Sollinger HW.
    Transplant Proc; 1994 Oct; 26(5):2569-70. PubMed ID: 7940794
    [No Abstract] [Full Text] [Related]

  • 7. Effect of anti-CD4 monoclonal antibody and cyclosporine A or a combination of both on chronic rejection in the rat aortic allograft model.
    Lácha J, Lehmann M, Chadimová M, Brock J, Havlícková J.
    Transplant Proc; 1994 Dec; 26(6):3242-3. PubMed ID: 7998129
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of rapamycin, RS 61443, cyclosporine, and low-dose heparin as treatment for transplant vasculopathy in a rat model of chronic allograft rejection.
    Schmid C, Heemann U, Azuma H, Tilney NL.
    Transplant Proc; 1995 Feb; 27(1):438-9. PubMed ID: 7879053
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. High local production of nitric oxide as a possible mechanism by which rapamycin prevents transplant arteriosclerosis.
    Pham SM, Shears LL, Kawaharada N, Li S, Venkataramanan R, Sehgal S.
    Transplant Proc; 1998 Jun; 30(4):953-4. PubMed ID: 9636385
    [No Abstract] [Full Text] [Related]

  • 11. Synergistic effect of 3M KCl-extracted donor antigens with cyclosporine or cyclosporine/rapamycin to prolong heart allograft survival in rats.
    Hamashima T, Stepkowski SM, Smith S, Kahan BD.
    Transplant Proc; 1994 Oct; 26(5):3053-5. PubMed ID: 7940960
    [No Abstract] [Full Text] [Related]

  • 12. Rapamycin and cyclosporine synergistically prolong heart and kidney allograft survival.
    Stepkowski SM, Kahan BD.
    Transplant Proc; 1991 Dec; 23(6):3262-4. PubMed ID: 1750091
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Rescue therapy with rapamycin blocks an ongoing process of heart allograft rejection.
    Ferraresso M, Wang ME, Stepkowski SM, Kahan BD.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):729. PubMed ID: 8438460
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Donor pretreatment with rapamycin delays rejection following intestinal allotransplantation.
    He G, Zhong R, Zhang Z, Garcia B, Black R, Duff J, Grant D.
    Transplant Proc; 1992 Jun; 24(3):1178. PubMed ID: 1604577
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.